Jersey City-based Organon has completed its acquisition of Dermavant Sciences Ltd. from Roivant. Dermavant is a company ...

Organon has completed the acquisition of Dermavant Sciences, a subsidiary of Roivant, expanding its dermatology portfolio. With the deal's closure, Organon has added Dermavant’s VTAMA (tapinarof) ...

VTAMA ® (tapinarof) cream, 1%, is a novel nonbiologic, non-steroidal topical therapy approved by the U.S. Food and Drug Administration (FDA) for treatment of mild, moderate, and severe plaque ...

“I would like to thank Kevin and the entire Organon team for their partnership in the acquisition of Dermavant,” said Mayukh Sukhatme, MD, President and Chief Investment Officer of Roivant.

As per an 8-K filing with the Securities and Exchange Commission dated October 28, 2024, Roivant Sciences Ltd. officially completed a strategic merger with Organon, a global healthcare company ...

BASEL, Switzerland - Organon (NYSE: OGN), a global healthcare company, has announced the completion of its acquisition of Dermavant Sciences Ltd., a dermatological company, from Roivant (NASDAQ ...

BASEL, Switzerland - Organon (NYSE: OGN), a global healthcare company, has announced the completion of its acquisition of Dermavant Sciences Ltd., a dermatological company, from Roivant (NASDAQ: ROIV) ...

CloseCurlyDoubleQuote; “I would like to thank Kevin and the entire Organon team for their partnership in the acquisition of Dermavant,” said Mayukh Sukhatme, MD, President and ...